default author photo

Patrizia Giannatempo

Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Oncology

Milano

Italy

SCHOLARLY PAPERS

2

DOWNLOADS

134

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A Systematic Review and Meta-Analysis on the Optimal Treatment Duration of CHEckpoint InhibitoRS in Solid Tumors: The OTHERS Study

Number of pages: 37 Posted: 08 Feb 2022
Sapienza University of Rome - Department of Maternal, Infantile, and Urological Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Laboratory of Methodology of Systematic Reviews and Guidelines Production, Grande Ospedale Metropolitano Niguarda - Department of Thoracic Oncology, University of Parma - Medical Oncology Unit, Università Vita-Salute San Raffaele - Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Oncology, University of Parma - Medical Oncology Unit, Azienda Ospedaliero Universitaria di Modena - Department of Oncology, Azienda Ospedaliero-Universitaria Careggi, Università Vita-Salute San Raffaele - Department of Medical Oncology, University of Insubria, Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Department of Oncology, Sapienza University of Rome - Department of Maternal, Infantile, and Urological Sciences and Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Oncology
Downloads 84 (777,583)

Abstract:

Loading...

Immunotherapy, duration, survival, solid tumors

2.

Primary Retroperitoneal Germ-Cell Tumours (pR-GCT): Evaluation of Treatment Outcomes of An International Collaboration (PRIMERE Study-IGG05)

Number of pages: 27 Posted: 28 Oct 2025
Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University of Cologne - University Hospital of Cologne, University of Cologne, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Comenius University, Veneto Institute of Oncology IOV - IRCCS, Veneto Institute of Oncology IOV - IRCCS, University of Groningen, University Medical Centre Groningen, Fondazione IRCCS Policlinico San Matteo, University of Pavia, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Pavia, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori and Fondazione IRCCS Istituto Nazionale dei Tumori
Downloads 50 (1,063,489)

Abstract:

Loading...

Primary Retroperitoneal Cancer, Germ Cell Tumor, Prognosis, Extragonadal Germ Cell Tumors